Avivomed
Avivomed is a startup headquartered in Roseville, United States, founded in 2021. It has raised at least $5.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Avivomed has raised at least $5.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Avivomed sits inside the Minneapolis region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Roseville
Related
- Innovation profile of Roseville
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Avivomed do?
Avivomed is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Avivomed raised?
At least $5.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Avivomed based?
Avivomed is headquartered in Roseville, United States.
When was Avivomed founded?
Avivomed was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.